APA (7th ed.) Citation

Jade Gauvin, Geneviève Frégeau, Hanan Elimam, Hanan Elimam, Hanan Elimam, Liliane Ménard, . . . Sylvie Marleau. (2023). A cyclic azapeptide ligand of the scavenger receptor CD36/SR-B2 reduces the atherosclerotic lesion progression and enhances plaque stability in apolipoprotein E-deficient mice. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Jade Gauvin, et al. A Cyclic Azapeptide Ligand of the Scavenger Receptor CD36/SR-B2 Reduces the Atherosclerotic Lesion Progression and Enhances Plaque Stability in Apolipoprotein E-deficient Mice. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Jade Gauvin, et al. A Cyclic Azapeptide Ligand of the Scavenger Receptor CD36/SR-B2 Reduces the Atherosclerotic Lesion Progression and Enhances Plaque Stability in Apolipoprotein E-deficient Mice. Frontiers Media S.A., 2023.